PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Mark Bower Selected Research
Highly Active Antiretroviral Therapy (HAART)
03/2008
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.
09/2006
The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
08/2006
Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma.
05/2006
A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
04/2006
The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe.
02/2006
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
08/2005
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
12/2004
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?
09/2003
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.
02/2003
HIV-related lung cancer in the era of highly active antiretroviral therapy.
11/2002
The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma.
03/2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Articles by Research Topic
Disease
9
Acquired Immunodeficiency Syndrome (AIDS)
04/2008 - 09/2003
8
Kaposi Sarcoma (Kaposi's Sarcoma)
06/2008 - 11/2002
5
Lymphoma (Lymphomas)
08/2006 - 03/2002
4
Neoplasms (Cancer)
05/2008 - 04/2004
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2008 - 08/2005
3
Giant Lymph Node Hyperplasia (Castleman's Disease)
12/2007 - 09/2004
1
Hepatocellular Carcinoma (Hepatoma)
03/2008
1
Hepatitis
03/2008
1
Hodgkin Disease (Hodgkin's Disease)
02/2008
1
Cholangiocarcinoma
08/2006
1
Anus Neoplasms (Anal Cancer)
12/2004
1
Neutropenia
11/2004
1
Hepatitis B
03/2004
1
AIDS-Related Lymphoma (Lymphoma, AIDS Related)
03/2004
1
Lung Neoplasms (Lung Cancer)
02/2003
Drug/Important Bio-Agent (IBA)
2
rituximab (Mabthera)
FDA Link
12/2007 - 12/2007
2
Protease Inhibitors (Protease Inhibitor)
IBA
11/2004 - 07/2003
1
pegylated liposomal doxorubicin
IBA
06/2008
1
Antidepressive Agents (Antidepressants)
IBA
05/2008
1
Cytarabine (Cytosar-U)
FDA Link
Generic
04/2006
1
eszopiclone (Lunesta)
FDA Link
11/2005
1
zopiclone (Zop)
IBA
11/2005
1
Paclitaxel (Taxol)
FDA Link
Generic
04/2005
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2004
1
Monoclonal Antibodies
IBA
09/2004
1
Interleukin-6 (Interleukin 6)
IBA
09/2004
1
Ritonavir (Norvir)
FDA Link
02/2004
1
Reverse Transcriptase Inhibitors
IBA
07/2003
Therapy/Procedure
12
Highly Active Antiretroviral Therapy (HAART)
03/2008 - 03/2002
4
Drug Therapy (Chemotherapy)
04/2008 - 11/2004
2
Combination Drug Therapy (Combination Chemotherapy)
03/2004 - 03/2002
1
Transplants (Transplant)
02/2008
1
Retreatment
12/2007
1
Immunotherapy
04/2004